Thirunavukkarasu K - Search Results

1

Long-term safety of tofacitinib for the treatment of rheumatoid arthritis up to 8.5 years: integrated analysis of data from the global clinical trials.

Cohen SB, Tanaka Y, Mariette X, Curtis JR, Lee EB, Nash P, Winthrop KL, Charles-Schoeman C, Thirunavukkarasu K, DeMasi R, Geier J, Kwok K, Wang L, Riese R, Wollenhaupt J. Cohen SB, et al. Among authors: thirunavukkarasu k. Ann Rheum Dis. 2017 Jul;76(7):1253-1262. doi: 10.1136/annrheumdis-2016-210457. Epub 2017 Jan 31. Ann Rheum Dis. 2017. PMID: 28143815 Free PMC article.

2

Treatment outcomes in patients with seropositive versus seronegative rheumatoid arthritis in Phase III randomised clinical trials of tofacitinib.

Bird P, Hall S, Nash P, Connell CA, Kwok K, Witcombe D, Thirunavukkarasu K. Bird P, et al. Among authors: thirunavukkarasu k. RMD Open. 2019 Feb 23;5(1):e000742. doi: 10.1136/rmdopen-2018-000742. eCollection 2019. RMD Open. 2019. PMID: 30886732 Free PMC article. Clinical Trial.

3

Tofacitinib, an Oral Janus Kinase Inhibitor: Pooled Efficacy and Safety Analyses in an Australian Rheumatoid Arthritis Population.

Hall S, Nash P, Rischmueller M, Bossingham D, Bird P, Cook N, Witcombe D, Soma K, Kwok K, Thirunavukkarasu K. Hall S, et al. Among authors: thirunavukkarasu k. Rheumatol Ther. 2018 Dec;5(2):383-401. doi: 10.1007/s40744-018-0118-2. Epub 2018 Jun 11. Rheumatol Ther. 2018. PMID: 29949132 Free PMC article.

4

Tofacitinib 5 mg Twice Daily in Patients with Rheumatoid Arthritis and Inadequate Response to Disease-Modifying Antirheumatic Drugs: A Comprehensive Review of Phase 3 Efficacy and Safety.

Bird P, Bensen W, El-Zorkany B, Kaine J, Manapat-Reyes BH, Pascual-Ramos V, Witcombe D, Soma K, Zhang R, Thirunavukkarasu K. Bird P, et al. Among authors: thirunavukkarasu k. J Clin Rheumatol. 2019 Apr;25(3):115-126. doi: 10.1097/RHU.0000000000000786. J Clin Rheumatol. 2019. PMID: 29794874 Free PMC article. Review.

5

Relationship between rheumatoid arthritis disease severity, health-related utility, and resource use in Australian patients: A cross-sectional, multicenter study.

Standfield L, Norris S, Harvey C, Elliot L, Riordan J, Hall S, Day R, Nash P, Thirunavukkarasu K, Robertson J, Palmer T. Standfield L, et al. Among authors: thirunavukkarasu k. Clin Ther. 2010 Jul;32(7):1329-42. doi: 10.1016/j.clinthera.2010.07.006. Clin Ther. 2010. PMID: 20678681

6

Frequency of undiagnosed psoriatic arthritis among psoriasis patients in Australian dermatology practice.

Spelman L, Su JC, Fernandez-Peñas P, Varigos GA, Cooper AJ, Baker CS, Lee M, Ring JM, Thirunavukkarasu K. Spelman L, et al. Among authors: thirunavukkarasu k. J Eur Acad Dermatol Venereol. 2015 Nov;29(11):2184-91. doi: 10.1111/jdv.13210. Epub 2015 Sep 14. J Eur Acad Dermatol Venereol. 2015. PMID: 26370225

7

Combining etanercept with traditional agents in the treatment of psoriasis: a review of the clinical evidence.

Foley PA, Quirk C, Sullivan JR, Dolianitis C, Hack SP, Thirunavukkarasu K, Cooper AJ. Foley PA, et al. Among authors: thirunavukkarasu k. J Eur Acad Dermatol Venereol. 2010 Oct;24(10):1135-43. doi: 10.1111/j.1468-3083.2010.03613.x. J Eur Acad Dermatol Venereol. 2010. PMID: 20337816 Review.

8

Disseminated nocardiosis in a bone marrow transplant recipient with chronic GVHD.

Bhave AA, Thirunavukkarasu K, Gottlieb DJ, Bradstock K. Bhave AA, et al. Among authors: thirunavukkarasu k. Bone Marrow Transplant. 1999 Mar;23(5):519-21. doi: 10.1038/sj.bmt.1701602. Bone Marrow Transplant. 1999. PMID: 10100569

9

Microwave-assisted alkali pre-treatment medium for fractionation of rice straw and catalytic conversion to value-added 5-hydroxymethyl furfural and lignin production.

Jasmine A, Rajendran M, Thirunavukkarasu K, Abinandan S, Vaidyanathan VK, Krishnamurthi T. Jasmine A, et al. Among authors: thirunavukkarasu k. Int J Biol Macromol. 2023 May 1;236:123999. doi: 10.1016/j.ijbiomac.2023.123999. Epub 2023 Mar 10. Int J Biol Macromol. 2023. PMID: 36906211

10

Outcomes of cVEMP and oVEMP in Individuals with Tinnitus and Normal Hearing.

Thirunavukkarasu K, Renifa J JM, Ramsankar SA. Thirunavukkarasu K, et al. Int Tinnitus J. 2022 Dec 1;26(2):133-138. doi: 10.5935/0946-5448.20220021. Int Tinnitus J. 2022. PMID: 36724362

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

54 results

Search Page